X Pan, N Liu, Q Zhang, K Wang, Y Li, YY Shan… - Bioorganic & Medicinal …, 2021 - Elsevier
Despite the success of imatinib in CML therapy through Bcr-Abl inhibition, acquired drug
resistance occurs over time in patients. In particular, the resistance caused by T315I …